Related Experiment Video
Updated: May 27, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome
Johan Wouter Jukema1,2, Nicolaas J Van Neer1, Michael Szarek3,4,5,6
1Department of Cardiology, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands.
Insights
High-sensitivity C-reactive protein (hsCRP) independently predicts major adverse cardiovascular events (MACE) after acute coronary syndrome (ACS). Both hsCRP and interleukin-6 (IL-6) predict death, offering complementary prognostic insights.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- High-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) are linked to adverse cardiovascular events post-acute coronary syndrome (ACS).
- The independent and complementary prognostic value of hsCRP and IL-6 after ACS remains unclear.
Purpose of the Study:
- To investigate the independent and complementary prognostic information of hsCRP and IL-6 in patients following ACS.
- To assess the predictive value of these biomarkers for major adverse cardiovascular events (MACE) and all-cause death.
Main Methods:
- Post hoc analysis of the ODYSSEY OUTCOMES trial involving 11,817 post-ACS patients.
- Proportional hazards models assessed the relationship between log-transformed hsCRP, IL-6 levels, and MACE/all-cause death.
- Adjustments were made for treatment assignment, demographics, LDL-C, and time since ACS.
Main Results:
- hsCRP independently predicted MACE (P < .0001), while IL-6 did not (P = .21).
- Both hsCRP and IL-6 independently predicted all-cause death (P < .0001 and P = .0003, respectively).
- Elevated risks for MACE and death were observed when both hsCRP and IL-6 were high, indicating complementary prognostic information.
Conclusions:
- hsCRP provides independent prognostic information for MACE in recent ACS patients.
- Both hsCRP and IL-6 are independent predictors of all-cause mortality post-ACS.
- Combined assessment of hsCRP and IL-6 offers complementary prognostic value beyond individual markers.
Background And Aims:
After acute coronary syndrome (ACS), high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) levels have been associated with risk of major adverse cardiovascular events (MACE). Whether the prognostic information provided by hsCRP and IL-6 is independent and complementary after ACS is unclear.
Methods:
The ODYSSEY OUTCOMES trial compared alirocumab with placebo in post-ACS patients on optimized statin therapy. In post hoc analyses, the relation between log-transformed hsCRP and IL-6 levels and risk of MACE and all-cause death was assessed in proportional hazards models.
Results:
A total of 11 817 patients had baseline hsCRP and IL-6 data; 1306 had a MACE primary endpoint and 458 died. Median hsCRP, IL-6, and low-density lipoprotein cholesterol (LDL-C) were 1.54 mg/L, 5.00 pg/ml, and 86 mg/dl, respectively. hsCRP and IL-6 had moderate correlation (r = 0.52). In models for one biomarker adjusted for the other biomarker, treatment assignment, age, sex, diabetes, LDL-C, and time since index ACS, hsCRP was a significant independent predictor of MACE (P < .0001) and IL-6 was not (P = .21); both independently predicted death (P < .0001 for hsCRP and P = .0003 for IL-6). Relationships did not depend on treatment (all Pinteraction > .25). When dichotomized at 2 mg/L (hsCRP) and 5 pg/ml (IL-6), risks of MACE and death were significantly elevated when both, but not when one marker was elevated.
Conclusions:
In patients with recent ACS, hsCRP independently predicted MACE, while both hsCRP and IL-6 predicted death. Together, the two markers provided complementary prognostic information. hsCRP conveys independent information on inflammatory risk beyond that provided by IL-6.
More Related Videos
06:29Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Inflammation III: Local and Systemic Effects
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pericarditis II: Clinical Features and Diagnostic Tests